65,437 trials
Fungal Infection
Primary: Single Dose Trough Concentration of IV Posaconazole (Cmin) — 318; 295; 467 ng/mL
de Novo Kidney Transplant Recipients · Renal Transplantation
Primary: Treatment Failure Rate — 3; 10; 2 Participants
Bladder Cancer
Primary: Recurrence Free Survival — 9.6; 16.4 months — p=0.056
Tobacco Use Disorder
Primary: Smoking Abstinence — 41; 18; 33; 19 percentage of participants — p=0.001
Muscle Spasticity
Primary: Physician Assessment of Spasticity
Healthy
Primary: Maximum Plasma Concentration (Cmax) — 130.58; 124.53 ng/mL
Chronic Obstructive Pulmonary Disease
Primary: Unpleasantness of Breathlessness — 72.5; 72.6 units on a scale
Erectile Dysfunction
Primary: Percentage of Participants With a Score of Greater Than or Equal to 22 in the Erectile Function (EF) Domain of the International Index of Erectile Function (IIEF)…
Overweight · Obesity
Primary: Least Squares (LS) Mean Percent Change in Body Weight From Baseline to Week 28 - Evaluable Population — -2.01; -5.47; -5.83; -6.85 Percentage change in kg — p=<0.0001
Atrial Fibrillation
Primary: Event Rate of Stroke/Systemic Embolism During the Intended-treatment Period — 1.62; 3.63 Percentage of events — p=<0.00001
Hyperparathyroidism, Primary
Primary: Cinacalcet Dose — 43.9 mg/day
Age Related Macular Degeneration · Geographic Atrophy
Primary: Difference in mm Squared of Cirrus HD-OCT Automated Measurements of the Illumination Areaa Under the RPE to Expert Manual Measurement of Areas of Hypofluorescence…
Diphtheria · Tetanus · Pertussis
Primary: Number of Participants With Antibody Persistence and Immunogenicity Booster Response to Vaccination With DTaP-Hep B-PRP~T Concomitantly With Oral Polio Vaccine (OPV)…
Schizophrenia · Schizoaffective Disorder
Primary: Change in Positive and Negative Syndrome Scale (PANSS) Score From the Start to the End of the Double-blind Treatment Phase (Week 0 to Week 14) — 67.55; 69.56; 67.42…
Neoplasms
Primary: Objective Response (OR) — 1 Participants with OR